Apellis Pharmaceuticals I... (APLS)

NASDAQ: APLS · Real-Time Price · USD

20.09

0.88 (4.58%)

At close: May 01, 2025, 3:59 PM

20.07

-0.07%

After-hours: May 01, 2025, 07:38 PM EDT

Apellis Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	781.37M	396.59M	75.42M	66.56M	250.65M	n/a	n/a	n/a	n/a
Cost of Revenue	117.72M	58.51M	5.64M	5.2M	25.05M	288.02M	127.92M	50.77M	n/a
Gross Profit	663.64M	338.08M	69.79M	61.36M	225.6M	-288.02M	-127.92M	-50.77M	n/a
Operating Income	-164.98M	-517.12M	-594.61M	-536.28M	-213.73M	-288.02M	-127.92M	-50.77M	-27.28M
Interest Income	12.77M	20.93M	8.91M	418K	4.16M	5.11M	2.96M	n/a	n/a
Pretax Income	-196.72M	-526.5M	-651.5M	-746M	-343.03M	-304.71M	-127.5M	-51.01M	-27.12M
Net Income	-197.88M	-528.63M	-652.17M	-746.35M	-344.87M	-309.82M	-127.5M	-51.01M	-27.12M
Selling & General & Admin	501.05M	500.81M	277.16M	176.77M	139.4M	67.05M	22.64M	10.46M	4.3M
Research & Development	327.57M	354.39M	387.24M	420.87M	299.92M	220.97M	105.29M	40.3M	22.98M
Other Expenses	n/a	n/a	-288K	1.36M	-501K	-175.31K	-110.76K	11.54K	157.71K
Operating Expenses	828.62M	855.2M	664.4M	597.64M	439.32M	288.02M	127.92M	50.77M	27.28M
Interest Expense	40.39M	29.58M	32.63M	13.24M	29.94M	5.28M	2.51M	96.92K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	946.35M	913.71M	670.03M	602.84M	464.37M	288.02M	127.92M	50.77M	27.28M
Income Tax Expense	1.16M	2.13M	669K	352K	1.84M	5.11M	-533.32K	250.61K	-27.28M
Shares Outstanding (Basic)	123.91M	118.68M	106.11M	84.42M	75.16M	62.23M	54.4M	13.87M	18.09M
Shares Outstanding (Diluted)	123.91M	118.68M	106.11M	84.42M	75.16M	62.23M	54.4M	13.87M	18.09M
EPS (Basic)	-1.6	-4.45	-6.15	-8.84	-4.59	-4.98	-2.34	-3.68	-1.5
EPS (Diluted)	-1.6	-4.45	-6.15	-8.84	-4.59	-4.98	-2.34	-3.68	-1.5
EBITDA	-154.53M	-495.21M	-617.39M	-731.27M	-312.23M	-298.83M	n/a	-50.9M	157.71K
EBIT	-156.32M	-496.92M	-618.88M	-732.76M	-313.09M	-288.01M	-124.99M	-50.91M	-27.12M
Depreciation & Amortization	1.8M	1.7M	1.49M	1.49M	859K	595.45K	127.92M	11.94K	27.28M